All News

Explaining what lymhedema feels like isn't always easy.

We spend so much time worrying what we can't control. What if we asked ourselves why and changed the thought process to worrying about only what we can control.

Imagine receiving two pieces of life-altering news in a matter of three days. One survivor not only experienced this, but came out the other side with a positive outlook and a humorous book, too.

From sugar to stress, are there really any lifestyle changes that can truly keep cancer at bay?

As part of the Bristol-Myers Squibb Coast 2 Coast 4 Cancer Research ride, 109 company employees rode from Oregon to New Jersey to help raise funds for the V Foundation for Cancer Research.

The FDA has granted a priority designation to a supplemental new drug application (sNDA) for Imbruvica (ibrutinib) for use in combination with Gazyva (obinutuzumab) for the frontline treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

The amount of preventative medicines given during hospital admission may be associated with an increased amount prescribed at discharge – resulting in higher costs and an increased risk for drug-drug interactions in patients with advanced lung cancer.

As marijuana use continues to increase across the US – and become legalized in more states – understanding the potential negative health effects is paramount.

Patients with the disease reported increased feelings of stigmatization, and results also showed that patients are viewed or treated differently than those with other cancer types.

In the first such clinical trial in the United States, researchers will evaluate focused ultrasound to breach the blood-brain barrier

More than 20 percent of patients with non–clear cell renal cell carcinoma (RCC) had a germline mutation, of which half had the potential to direct systemic therapy.

Experts at Roswell Park Comprehensive Cancer Center discovered a way to assess if a kidney tumor is benign or malignant, potentially sparing many from having to undergo surgery.

Children who suffer from a highly aggressive and deadly type of brain tumor may have new hope when it comes to treatment options.

Memories of a modern day mastectomy

The panelists acknowledged that many individuals face barriers to receiving regular skin check-ups. Some people – especially those in rural areas – may not have a dermatologist near them. And even if they do make it in to a doctor’s office for a skin check-up, they may not be checked as thoroughly as they should be.

The Food and Drug Administration has granted LOXO-292 a breakthrough therapy designation for the treatment of patients with advanced RET fusion–positive thyroid cancer who require systemic therapy, have progressed on prior treatment, and have no other acceptable alternative treatment options, according to a statement from Loxo Oncology, the developer of the selective RET inhibitor.

It's not ghosts and ghouls... it's a reminder of the past.

The National Comprehensive Cancer Network updated its Clinical Practice Guidelines to add two new options for the frontline treatment of patients with kidney cancer.

Please, the words "free boob job" and "breast cancer reconstruction" never belong in the same sentence.

New research indicates that aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) or naproxen (Aleve) could not only reduce the risk of ovarian cancer, but also improve survival with daily use.

Lynn Schuchter, M.D., discussed immunotherapy and BRAF/MEK inhibition at the Melanoma Action Coalition’s Fall Conference.

Brain cancer survivors are living longer, highlighting the importance of survivorship care for this population.

Alejandra Campoverdi shares her experience with having a BRCA2 mutation and explains how the Well Women Coalition is helping to start the conversation among women of color across the country.

Survivors who share their voices through blog posts have a big responsibility. Learn how to manage it here.

New drug regimens are not only personalizing the treatment of patients with mantle cell lymphoma, but they’re also improving outcomes, too, explained Chaitra S. Ujjani, M.D.

Cancer took my smile away, but only for a while. Helping others understand what a cancer diagnosis is like will help improve the experience for everyone.

The Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee voted 16-0 in support of the agency granting approval to CT-P10, a biosimilar of Rituxan (rituximab), which is a drug used to treat non-Hodgkin lymphoma.

The thinking and memory problems often experienced by patients after cancer treatment may also be linked to a gene associated with Alzheimer's disease risk.